Biologics for Treating Rheumatoid Arthritis – Unveiling the Power of Biologic Infusions at the Site of Care
Rheumatoid Arthritis (RA), a chronic autoimmune disorder affecting over 1.3 million Americans, can be debilitating and significantly reduce the quality of life for those afflicted.
Fortunately, advances in medical science have led to the development of biologic therapies that have revolutionized the management of RA.
As a physician, improving treatment outcomes, patient compliance, and helping patients live their best lives are among your top priorities. Reaching these goals is greatly enhanced when providers offer in-office biologic therapy at their existing practice.
Watch the video: Biologics for Treating Rheumatoid Arthritis – Unveiling the Power of Biologic Infusions at the Site of Care
The Biologic Breakthrough
Biologics are a class of drugs that have transformed the treatment landscape for RA. Unlike traditional disease-modifying antirheumatic drugs (DMARDs), biologics are engineered using living cells and proteins to target specific immune system components responsible for the inflammation and joint damage seen in RA.
This targeted approach offers enhanced efficacy and reduces the risk of widespread immune suppression.
Key Biologic Players in the Treatment of RA
Remicade® is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α). By neutralizing TNF-α, Remicade® suppresses inflammation and halts the progression of joint damage. This biologic has demonstrated impressive results in reducing pain and improving joint function.
Certolizumab pegol, marketed as Cimzia®, is another TNF inhibitor. Cimzia® is administered via subcutaneous injection and has shown great promise in quickly controlling RA symptoms and preventing further damage.
Tocilizumab, commercially known as Actemra®, targets interleukin-6 (IL-6) receptors, which play a significant role in RA-related inflammation.
By inhibiting IL-6 signaling, Actemra® effectively reduces joint inflammation and damage. It is available in both intravenous and subcutaneous formulations.
Golimumab, the active ingredient in Simponi Aria®, targets TNF-α. Administered intravenously in a 30-minute infusion, Simponi Aria® offers a convenient option for moderate to severe RA patients seeking in-office infusion treatment.
Abatacept, or Orencia®, modulates T-cell activation by disrupting the interaction between antigen-presenting cells and T cells. This unique action mechanism helps temper the autoimmune response responsible for RA symptoms. Orencia® is available in intravenous and subcutaneous forms.
Rituximab, or Rituxan®, Is a Chimeric Monoclonal Antibody that targets CD20-positive B cells, effectively reducing autoantibody production and inflammation.
Rituxan® is an excellent alternative for patients who have not responded to TNF inhibitors.
Patient Experience and the Role of In-Office Infusion Management
Biologics offer a promising avenue for managing RA, but successful treatment requires careful administration and monitoring.
In-office infusion management services, such as those offered by Altus Biologics, are pivotal in ensuring patient safety and treatment adherence.
Patients undergoing in-office infusions can expect a comfortable and controlled environment where medical professionals closely monitor their reactions and vitals.
Our infusion management services also offer the opportunity for real-time adjustments if adverse events occur, fostering a higher level of patient confidence.
Benefits of Partnering with Altus Biologics
Physicians seeking to optimize RA treatment for their patients can greatly benefit from collaborating with Altus Biologics.
As a physician, you can focus on patient care and treatment strategies while minimizing administrative burdens when you entrust your biologic infusion management to us.
Altus Biologics’ expertise ensures seamless infusion processes, improved patient outcomes, and enhanced patient satisfaction.
These are some of the benefits you receive when partnering with Altus Biologics:
Expertise and Convenience: Our staff of experienced healthcare professionals specializes in administering biologic therapies.
Your patients receive treatment in a comfortable and controlled environment at your existing care site, ensuring proper drug administration and monitoring.
Optimal Patient Compliance: Regular infusion sessions are crucial for maintaining therapeutic drug levels. In-office infusion centers help ensure patients adhere to their treatment schedule, reducing the risk of treatment gaps or disruptions.
Enhanced Safety: Our state-of-the-art in-office infusion centers follow strict protocols to ensure patient safety during administration. Our infusion nurses will monitor your patients for potential adverse reactions and promptly address any issues.
Efficient Resource Utilization: Partnering with a top-rated infusion management service allows physicians to focus on patient care and treatment decisions while we expertly handle all the logistical aspects of your in-office infusion suite.
Altus Biologics has the knowledge and experience to guarantee the success of your infusion suite. Call today to learn more about our services and how we can work together to improve patient lives.